- Product Details
Keywords
- Eptifibatide
- Eptifibatide Acetate
- 148031-34-9
Quick Details
- ProName: 98% up by HPLC, GMP Eptifibatide Aceta...
- CasNo: 148031-34-9
- Molecular Formula: C35H49N11O9S2
- Appearance: White powder
- Application: pharma grade
- DeliveryTime: in 7 days after your payment
- PackAge: 1g/vial, 10g/vial, or as your requirem...
- Port: Shanghai/Beijing/Hangzhou
- ProductionCapacity: 100 Kilogram/Month
- Purity: 98% up
- Storage: Dry place
- Transportation: cool&dry
- LimitNum: 10 Gram
Superiority
Why is SINOWAY:
1) Specialized in pharmaceutical and healthcare industrial for 34 years.
2) ISO 9001:2015 & SGS audited supplier .
3) Accept various payment terms : T.T 30-60 days.
4) We have warehouse in USA with quickly shipment .
5) We can do different terms of FOB ,CIF/CIP ,DDP ...
Details
Product name |
Eptifibatide acetate |
Sequence |
Mpr-Har-Gly-Asp-Trp-Pro-Cys-NH2 |
CAS No. |
188627-80-7 (Eptifibatide (net)), 148031-34-9 (Eptifibatide acetate) |
Molecular Formula |
C35H49N11O9S2 |
Molecular Weight |
832.4 |
Molecule Structure |
|
Quality Standard |
98% up by HPLC, GMP |
Appearance |
White slightly yellwish powder |
|
Items |
Specification |
Results |
Appearance |
White slightly yellwish powder |
Conforms |
Purity(HPLC) |
> 98% |
99.57% |
Peptide |
≥ 80% |
|
Specific optical rotation |
-53- -57°(C=5, 1% Acetic acid) |
-55.6° |
Solubility |
Soluble in water and 1% acetic acid at a concentration of ≥ 1mg/ml to give a clear, colorless solution |
Conforms |
Related substances (HPLC) |
Total impurities: ≤ 1.5% |
0.6% 0.2% |
Water (Karl Fischer) |
≤ 5.0 % |
3.8% |
Acetic acid (HPLC) |
≤ 10.0% |
8.7% |
Bacterial endotoxins |
< 10EU/mg |
Conforms |
Mass balance |
95.0%-105.% |
98.11% |
DMF (GC) |
≤0.088% |
Conforms |
can |
≤0.041% |
Conforms |
Conclusion |
Complies with the standard. |
Function of Eptifibatide acetate
Eptifibatide acetate is a cyclic heptapeptide, a glycoprotein IIb/IIIa receptor inhibitor, and has antiplatelet activity.
Application of Eptifibatide acetate
Eptifibatide acetate is used for the treatment of acute coronary syndrome (unstable angina pectoris/non-ST-elevation myocardial infarction), including patients who will receive medical treatment or who are planning to undergo percutaneous coronary intervention (PCI).